Apolipoprotein B is a better marker than non-HDL-cholesterol for the metabolic syndrome in Koreans

Jee Hye Han, Hye Soon Park, Jeong A. Kim, Seon Mee Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Apolipoprotein B (apoB) concentration reflects the number of atherogenic particles and is closely associated with atherosclerosis. Non-HDL-cholesterol (non-HDL-C) has been considered a therapeutic target for patients with hypertriglyceridemia. We compared the predictive values of apoB and non-HDL-C for the metabolic syndrome (MetS) in 3335 Korean adults (mean age, 45.2 years) who participated consecutively in a health examination in a university hospital. Anthropometry, blood pressure, fasting glucose, lipid profiles and apoB were measured. MetS, as defined by a modification of the NCEP-ATP III criteria, was present in 22.1% of men and 16.1% of women. Among the components of the MetS, triglycerides showed the strongest correlation with apoB (r = 0.393, P < 0.001 in men, and r = 0.326, P < 0.001 in women) and non-HDL-C (r = 0.376, P < 0.001 in men, and r = 0.349, P < 0.001 in women). When apoB and non-HDL-C were mutually adjusted, the ORs for the MetS of non-HDL-C were not significant. As a function of the quartile of apoB levels, the ORs for the MetS were 2.04 (1.26-3.30), 3.54 (2.11-5.93), and 5.38 (3.16-9.17) in men (P for trend <0.001) and 3.75 (1.42-9.87), 5.55 (2.09-14.69), and 13.41 (5.02-35.79) in women (P for trend <0.001), respectively. These findings indicate that apoB is a better marker than non-HDL-C for identifying the MetS among Koreans.

Original languageEnglish
Pages (from-to)333-338
Number of pages6
JournalAtherosclerosis
Volume197
Issue number1
DOIs
Publication statusPublished - 2008 Mar 1

Fingerprint

Apolipoproteins B
Cholesterol
Anthropometry
Hypertriglyceridemia
Fasting
Atherosclerosis
Triglycerides
Adenosine Triphosphate
Blood Pressure
Lipids
Glucose
Health

Keywords

  • Apolipoprotein B
  • Korean
  • Metabolic syndrome
  • Non-HDL-cholesterol
  • Prediction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Apolipoprotein B is a better marker than non-HDL-cholesterol for the metabolic syndrome in Koreans. / Han, Jee Hye; Park, Hye Soon; Kim, Jeong A.; Kim, Seon Mee.

In: Atherosclerosis, Vol. 197, No. 1, 01.03.2008, p. 333-338.

Research output: Contribution to journalArticle

Han, Jee Hye ; Park, Hye Soon ; Kim, Jeong A. ; Kim, Seon Mee. / Apolipoprotein B is a better marker than non-HDL-cholesterol for the metabolic syndrome in Koreans. In: Atherosclerosis. 2008 ; Vol. 197, No. 1. pp. 333-338.
@article{4a654047f80847968803e20d2282ece0,
title = "Apolipoprotein B is a better marker than non-HDL-cholesterol for the metabolic syndrome in Koreans",
abstract = "Apolipoprotein B (apoB) concentration reflects the number of atherogenic particles and is closely associated with atherosclerosis. Non-HDL-cholesterol (non-HDL-C) has been considered a therapeutic target for patients with hypertriglyceridemia. We compared the predictive values of apoB and non-HDL-C for the metabolic syndrome (MetS) in 3335 Korean adults (mean age, 45.2 years) who participated consecutively in a health examination in a university hospital. Anthropometry, blood pressure, fasting glucose, lipid profiles and apoB were measured. MetS, as defined by a modification of the NCEP-ATP III criteria, was present in 22.1{\%} of men and 16.1{\%} of women. Among the components of the MetS, triglycerides showed the strongest correlation with apoB (r = 0.393, P < 0.001 in men, and r = 0.326, P < 0.001 in women) and non-HDL-C (r = 0.376, P < 0.001 in men, and r = 0.349, P < 0.001 in women). When apoB and non-HDL-C were mutually adjusted, the ORs for the MetS of non-HDL-C were not significant. As a function of the quartile of apoB levels, the ORs for the MetS were 2.04 (1.26-3.30), 3.54 (2.11-5.93), and 5.38 (3.16-9.17) in men (P for trend <0.001) and 3.75 (1.42-9.87), 5.55 (2.09-14.69), and 13.41 (5.02-35.79) in women (P for trend <0.001), respectively. These findings indicate that apoB is a better marker than non-HDL-C for identifying the MetS among Koreans.",
keywords = "Apolipoprotein B, Korean, Metabolic syndrome, Non-HDL-cholesterol, Prediction",
author = "Han, {Jee Hye} and Park, {Hye Soon} and Kim, {Jeong A.} and Kim, {Seon Mee}",
year = "2008",
month = "3",
day = "1",
doi = "10.1016/j.atherosclerosis.2007.05.021",
language = "English",
volume = "197",
pages = "333--338",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Apolipoprotein B is a better marker than non-HDL-cholesterol for the metabolic syndrome in Koreans

AU - Han, Jee Hye

AU - Park, Hye Soon

AU - Kim, Jeong A.

AU - Kim, Seon Mee

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Apolipoprotein B (apoB) concentration reflects the number of atherogenic particles and is closely associated with atherosclerosis. Non-HDL-cholesterol (non-HDL-C) has been considered a therapeutic target for patients with hypertriglyceridemia. We compared the predictive values of apoB and non-HDL-C for the metabolic syndrome (MetS) in 3335 Korean adults (mean age, 45.2 years) who participated consecutively in a health examination in a university hospital. Anthropometry, blood pressure, fasting glucose, lipid profiles and apoB were measured. MetS, as defined by a modification of the NCEP-ATP III criteria, was present in 22.1% of men and 16.1% of women. Among the components of the MetS, triglycerides showed the strongest correlation with apoB (r = 0.393, P < 0.001 in men, and r = 0.326, P < 0.001 in women) and non-HDL-C (r = 0.376, P < 0.001 in men, and r = 0.349, P < 0.001 in women). When apoB and non-HDL-C were mutually adjusted, the ORs for the MetS of non-HDL-C were not significant. As a function of the quartile of apoB levels, the ORs for the MetS were 2.04 (1.26-3.30), 3.54 (2.11-5.93), and 5.38 (3.16-9.17) in men (P for trend <0.001) and 3.75 (1.42-9.87), 5.55 (2.09-14.69), and 13.41 (5.02-35.79) in women (P for trend <0.001), respectively. These findings indicate that apoB is a better marker than non-HDL-C for identifying the MetS among Koreans.

AB - Apolipoprotein B (apoB) concentration reflects the number of atherogenic particles and is closely associated with atherosclerosis. Non-HDL-cholesterol (non-HDL-C) has been considered a therapeutic target for patients with hypertriglyceridemia. We compared the predictive values of apoB and non-HDL-C for the metabolic syndrome (MetS) in 3335 Korean adults (mean age, 45.2 years) who participated consecutively in a health examination in a university hospital. Anthropometry, blood pressure, fasting glucose, lipid profiles and apoB were measured. MetS, as defined by a modification of the NCEP-ATP III criteria, was present in 22.1% of men and 16.1% of women. Among the components of the MetS, triglycerides showed the strongest correlation with apoB (r = 0.393, P < 0.001 in men, and r = 0.326, P < 0.001 in women) and non-HDL-C (r = 0.376, P < 0.001 in men, and r = 0.349, P < 0.001 in women). When apoB and non-HDL-C were mutually adjusted, the ORs for the MetS of non-HDL-C were not significant. As a function of the quartile of apoB levels, the ORs for the MetS were 2.04 (1.26-3.30), 3.54 (2.11-5.93), and 5.38 (3.16-9.17) in men (P for trend <0.001) and 3.75 (1.42-9.87), 5.55 (2.09-14.69), and 13.41 (5.02-35.79) in women (P for trend <0.001), respectively. These findings indicate that apoB is a better marker than non-HDL-C for identifying the MetS among Koreans.

KW - Apolipoprotein B

KW - Korean

KW - Metabolic syndrome

KW - Non-HDL-cholesterol

KW - Prediction

UR - http://www.scopus.com/inward/record.url?scp=39449088821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449088821&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2007.05.021

DO - 10.1016/j.atherosclerosis.2007.05.021

M3 - Article

C2 - 17628565

AN - SCOPUS:39449088821

VL - 197

SP - 333

EP - 338

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -